ORLANDO, FL / ACCESSWIRE / August 23, 2024 / RedChip Companies will air interviews with OKYO Pharma Ltd. (Nasdaq: OKYO) and SolarMax Technology, Inc. (Nasdaq: SMXT) on Bloomberg TV's sponsored RedChip Small Stocks, Big Money™ show this Saturday, August 24th at 7pm ET. Bloomberg TV is available in an estimated 73 million homes across the United States.
You can find the full interview at the following link:
OKYO Pharma CEO Dr. Gary S. Jacob appeared on Bloomberg TV's RedChip Small Stocks Big Money™ show in an exclusive interview to provide a company update. OKYO is a clinical-stage biopharmaceutical company developing innovative therapies for two areas of unmet medical need: dry eye disease (DED) and neuropathic corneal pain (NCP). OKYO's lead candidate, OK-101, leveraging a proprietary lipid-binding chemerin peptide, is designed to address inflammation and pain more effectively than current therapies. A recent Phase 2 study for DED showed notable improvement in both symptoms and signs in just 15 days, with a favorable safety profile and no drug-related serious adverse events. Additionally, OK-101 also offers a significant opportunity to treat an eye disease called NCP, where there are no FDA-approved drugs to treat patients suffering from acute and chronic eye diseases. OKYO has strong patent protection through at least 2039, plus an experienced management team and a track record of FDA-approved clinical development, positioning the company strongly for future growth in ophthalmic care.
SolarMax CEO David Hsu appeared on Bloomberg TV's RedChip Small Stocks, Big Money™ show to provide a company update. Founded in 2008 and based in California, SolarMax has successfully completed over 15,000 installations. The company's expansion into the Chinese market, which began in 2016 and reached a peak of $96 million in annual sales in 2021, significantly strengthened the company's end-to-end commercial solar development services and is now beginning to strategically expand in the United States. SolarMax has announced large-scale commercial solar projects in Las Vegas, Nevada and San Jose, California for Q3 2025 and is focused on building a strong deal pipeline in the United States and China to fuel growth in the coming years.
About OKYO
OKYO Pharma Limited (NASDAQ:OKYO) is a clinical-stage biopharmaceutical company with common shares listed on the NASDAQ Capital Market developing innovative therapeutics for the treatment of DED and NCP. OKYO is focused on the discovery and development of novel molecules to treat inflammatory DED and ocular pain. In addition to the recently completed Phase 2 DED study, OKYO also plans to initiate a Phase 2 study of OK-101 to treat NCP in patients with this debilitating disease. For more information, please visit www.okyopharma.com.
About SolarMax Technology
Based in California and founded in 2008, SolarMax is a leader in the solar and renewable energy sector focused on making sustainable energy accessible and affordable. SolarMax has established a strong presence in California and began operations in China in 2016. With strategic initiatives to expand its commercial solar development services and LED lighting solutions in the U.S., SolarMax is positioning itself for robust growth and expanding its residential solar business. For more information, please visit www.solarmaxtech.com.
About RedChip
RedChip Companies, an Inc. 5000 company, is an international investor relations, media and research firm focused on micro- and small-cap companies. For 32 years, RedChip has delivered tangible, measurable results to its clients. Our newsletter, “Small Stocks, Big Money™,” is distributed online to 60,000 investors weekly. RedChip has developed the industry's most comprehensive platform of services for micro- and small-cap companies. These services include a worldwide distribution network for equity research, retail and institutional roadshows in major U.S. cities, outbound marketing to stockbrokers, RIAs, institutional investors and family offices, a digital media investor relations platform that has generated millions of unique investor opinions, investor webinars and group calls, a television show, “Small Stocks, Big Money™,” that airs weekly on Bloomberg US, television commercials in regional and national markets, corporate and product videos, and website design. We also offer traditional investor relations services including press release writing, investor presentation development, quarterly conference call scripting, strategy consulting, fundraising and more.
For more information about RedChip products and services, please visit:
https://www.redchip.com/corporate/investor_relations
“Discover Tomorrow's Best Companies Today”™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Join our mailing list: https://www.redchip.com/newsletter/latest
contact:
Dave Gentry
Red Chip Companies Inc.
1-407-644-4256
(email address protected)
– end –
Source: RedChip
